{"id":"https://genegraph.clinicalgenome.org/r/5fd1533d-67cc-4675-aecd-58f55adcbf5dv1.0","type":"EvidenceStrengthAssertion","dc:description":"The *DDX11* gene is located on chromosome 12 at 12p11.21 and encodes the DEAD/H-Box Helicase 11, which is involved in the maintenance of genomic stability and cohesion of chromosome arms and centromeres in nucleocytoplasm or in mitotic phase. *DDX11* was first reported in relation to autosomal recessive Warsaw breakage syndrome in 2010 (van der Lelij et al. 2010, PMID: 20137776). Warsaw breakage syndrome is a rare disorder with typical clinical features including growth delay, facial dysmorphia, microcephaly, hearing loss due to cochlear malformations and, at cytological level, sister chromatid cohesion defects. Eighteen variants (ten missense, three frameshift, two nonsense, one intronic, one deletion, and one insertion) have been reported in 11 probands in six publications (PMIDs: 20137776, 23033317, 30216658, 30924321, 32855419, 36703504). The mechanism of pathogenicity at this time is reported to be loss of function. This gene-disease relationship is also supported by functional alteration in patient cells, rescue in patient cells, biochemical function studies, and a zebrafish model (PMIDs: 20137776, 26089203). In summary, there is definitive evidence supporting the relationship between *DDX11* and autosomal recessive Warsaw breakage syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date February 21st, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5fd1533d-67cc-4675-aecd-58f55adcbf5d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2025-02-21T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2025-04-08T15:20:09.365Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5aab052-4c47-4807-b754-533a015c95b9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/170dbcf0-8701-498e-8ce4-84515666fa68","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/170dbcf0-8701-498e-8ce4-84515666fa68_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"DDX11 expression and localization in WABS01 cells expressing different DDX11 versions were assessed by immunofluorescence. G57R, S857R, and C705Y variants showed substantially increased cytoplasmic retention and a more punctuate staining pattern, while WT and R140Q localized to nucleus.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/170dbcf0-8701-498e-8ce4-84515666fa68_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","allele":{"id":"https://genegraph.clinicalgenome.org/r/884de796-317e-4ea7-8e3a-8939e6c49284","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2114G>A (p.Cys705Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384248076"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3fd07f55-0622-4933-b7f7-61999e7d3fa8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fd07f55-0622-4933-b7f7-61999e7d3fa8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","allele":{"id":"https://genegraph.clinicalgenome.org/r/49aac151-cc2c-43c7-9f90-b1d9c579e540","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.1930G>A (p.Val644Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3374819"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d5aab052-4c47-4807-b754-533a015c95b9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","rdfs:label":"van Schie_WABS04","allele":[{"id":"https://genegraph.clinicalgenome.org/r/49aac151-cc2c-43c7-9f90-b1d9c579e540"},{"id":"https://genegraph.clinicalgenome.org/r/884de796-317e-4ea7-8e3a-8939e6c49284"}],"detectionMethod":"Bi-allelic variants in DDX11 were detected in these patients using whole exome sequencing and/or RNA sequencing, which they confirmed using Sanger sequencing of genomic DNA and cDNA","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0004209","obo:HP_0000007","obo:HP_0000252","obo:HP_0001249","obo:HP_0001000","obo:HP_0008897","obo:HP_0000365"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3fd07f55-0622-4933-b7f7-61999e7d3fa8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/170dbcf0-8701-498e-8ce4-84515666fa68_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/36974271-e7a6-4856-a68a-b03a32e5281d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f38c4ea9-af6d-41b3-8328-16e4fd7ecdd4","type":"EvidenceLine","dc:description":"The variant escapes NMD, and the proband is homozygous/consanguineous","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f38c4ea9-af6d-41b3-8328-16e4fd7ecdd4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b50c78c-f695-4ef9-a1af-eb6f5cc1cead","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2638dup (p.Ala880GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6501931"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/36974271-e7a6-4856-a68a-b03a32e5281d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","rdfs:label":"Alkhunaizi_Patient 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b50c78c-f695-4ef9-a1af-eb6f5cc1cead"},"detectionMethod":"WES was performed for all patients","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001999","obo:HP_0000007","obo:HP_0000365","obo:HP_0004209","obo:HP_0008897","obo:HP_0012443","obo:HP_0001249","obo:HP_0000252","obo:HP_0004691","obo:HP_0001511","obo:HP_0008586"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f38c4ea9-af6d-41b3-8328-16e4fd7ecdd4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/40bafda4-aee9-4a51-8ac5-ef928b1e44de_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77eed84e-ca8f-42ca-ad28-95a5dd7ceda5","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77eed84e-ca8f-42ca-ad28-95a5dd7ceda5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137776","allele":{"id":"https://genegraph.clinicalgenome.org/r/10c15106-06b4-427e-a494-d7d79ff964b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2271+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212894"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ede45665-c4a9-47e7-9b51-1743b6438461","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ede45665-c4a9-47e7-9b51-1743b6438461_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137776","allele":{"id":"https://genegraph.clinicalgenome.org/r/99115143-2143-4e58-b08b-fc4c2e99b0af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2689_2691del (p.Lys897del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212895"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/40bafda4-aee9-4a51-8ac5-ef928b1e44de","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137776","rdfs:label":"van der Lelij_case 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/99115143-2143-4e58-b08b-fc4c2e99b0af"},{"id":"https://genegraph.clinicalgenome.org/r/10c15106-06b4-427e-a494-d7d79ff964b6"}],"detectionMethod":"Protein products from candidate genes (genes for which a role in sister chromatid cohesion has been described in the literature) were investigated by immunoblot analysis of lymphoblast and fibroblast lysates.","firstTestingMethod":"Other","phenotypes":["obo:HP_0000218","obo:HP_0001511","obo:HP_0001034","obo:HP_0001249","obo:HP_0004209","obo:HP_0000965","obo:HP_0001263","obo:HP_0000007","obo:HP_0008586","obo:HP_0008897","obo:HP_0000252","obo:HP_0004691","obo:HP_0001629","obo:HP_0000365","obo:HP_0000588"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/77eed84e-ca8f-42ca-ad28-95a5dd7ceda5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ede45665-c4a9-47e7-9b51-1743b6438461_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/98606a7c-ee10-4ce6-a5c6-5d1ef8b958d0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4d99a14-2019-440b-acae-ec8b5282f77b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4d99a14-2019-440b-acae-ec8b5282f77b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","allele":{"id":"https://genegraph.clinicalgenome.org/r/57ac5f4b-707f-4a4f-bcf2-0653fa425128","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.606del (p.Tyr202Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA946166988"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5e37ccb7-e958-4934-934f-7dc0fb47a53b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e37ccb7-e958-4934-934f-7dc0fb47a53b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d393402-6e8d-4211-9d15-d8b445913583","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2372G>A (p.Arg791Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6501773"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/98606a7c-ee10-4ce6-a5c6-5d1ef8b958d0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","rdfs:label":"Alkhunaizi_Patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8d393402-6e8d-4211-9d15-d8b445913583"},{"id":"https://genegraph.clinicalgenome.org/r/57ac5f4b-707f-4a4f-bcf2-0653fa425128"}],"detectionMethod":"WES was performed on all patients","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001511","obo:HP_0012443","obo:HP_0008586","obo:HP_0001249","obo:HP_0008897","obo:HP_0004209","obo:HP_0001999","obo:HP_0000007","obo:HP_0000365","obo:HP_0004691","obo:HP_0000252"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5e37ccb7-e958-4934-934f-7dc0fb47a53b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c4d99a14-2019-440b-acae-ec8b5282f77b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/eb118291-9a26-4359-85f8-5534cb7f663c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bf6d497-b305-4c2f-a0e8-e0def9ae9fa5","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bf6d497-b305-4c2f-a0e8-e0def9ae9fa5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30924321","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdef60e8-1361-4423-a386-fce404026182","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.907_920del (p.Lys303GlufsTer22)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2025565272"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/47b43178-b68f-4ef1-bdbe-a608fdfe042c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47b43178-b68f-4ef1-bdbe-a608fdfe042c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The authors used a fluorescence-based helicase assay, and biochemical analysis showed that the WT recombinant DDX11 efficiently unwound DNA, whereas the Leu836Pro mutant had no helicase activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/47b43178-b68f-4ef1-bdbe-a608fdfe042c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30924321","allele":{"id":"https://genegraph.clinicalgenome.org/r/4e6c639e-aa3e-4965-8edc-88291e2a7604","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2507T>C (p.Leu836Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384249910"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/eb118291-9a26-4359-85f8-5534cb7f663c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30924321","rdfs:label":"Bottega_first sister","allele":[{"id":"https://genegraph.clinicalgenome.org/r/fdef60e8-1361-4423-a386-fce404026182"},{"id":"https://genegraph.clinicalgenome.org/r/4e6c639e-aa3e-4965-8edc-88291e2a7604"}],"detectionMethod":"DDX11 was sequenced, variants confirmed using Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000365","obo:HP_0001511","obo:HP_0000341","obo:HP_0000340","obo:HP_0000007"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/47b43178-b68f-4ef1-bdbe-a608fdfe042c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9bf6d497-b305-4c2f-a0e8-e0def9ae9fa5_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/83378a98-3faf-4fcf-9b4d-20e99e77d766_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b5fd474-255a-47ac-9fa6-86ca1af034e5","type":"EvidenceLine","dc:description":"The SD-GCEP only upgrades one variant to 0.5 points for functional evidence when homozygous.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b5fd474-255a-47ac-9fa6-86ca1af034e5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Quantitative analysis of data from helicase activity of DDX11-R263Q and DDX11-WT on forked duplex DNA substrate was performed, and the percent substrate unwound by the DDX11-R263Q helicase was much less than the WT.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2b5fd474-255a-47ac-9fa6-86ca1af034e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23033317","allele":{"id":"https://genegraph.clinicalgenome.org/r/e49e6100-b2b0-4158-a452-1efc78c08740","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.788G>A (p.Arg263Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130693"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/83378a98-3faf-4fcf-9b4d-20e99e77d766","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23033317","rdfs:label":"Capo-Chichi_V-I","allele":{"id":"https://genegraph.clinicalgenome.org/r/e49e6100-b2b0-4158-a452-1efc78c08740"},"detectionMethod":"Authors first performed whole-genome SNP genotyping in two affected siblings, then exome capture, and confirmed variants with Sanger sequencing","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0000365","obo:HP_0008897","obo:HP_0004209","obo:HP_0000007","obo:HP_0001252","obo:HP_0008586"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2b5fd474-255a-47ac-9fa6-86ca1af034e5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9cee6b9e-f00a-4da3-b115-15c39e0da311_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5872ddd-bff5-4954-8da1-695385955a13","type":"EvidenceLine","dc:description":"The SD-GCEP only scores one variant at 0.5 points for functional evidence when homozygous","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5872ddd-bff5-4954-8da1-695385955a13_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The level of DDX11-R378P for two different isolates was significantly increased in those transfected cells that had been treated with MG132. In the absence of the proteasome inhibitor MG132, expression of DDX11-R378P was 54 ± 2 % of DDX11-WT.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a5872ddd-bff5-4954-8da1-695385955a13_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","allele":{"id":"https://genegraph.clinicalgenome.org/r/8149207b-ecec-42d8-8953-bffce2ce59db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.1133G>C (p.Arg378Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6501109"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9cee6b9e-f00a-4da3-b115-15c39e0da311","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","rdfs:label":"Alkhunaizi_Patient 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/8149207b-ecec-42d8-8953-bffce2ce59db"},"detectionMethod":"WES was performed for all patients","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0008897","obo:HP_0001249","obo:HP_0001631","obo:HP_0008586","obo:HP_0000007","obo:HP_0004691","obo:HP_0001252","obo:HP_0012443","obo:HP_0001511","obo:HP_0000252","obo:HP_0000365","obo:HP_0001034","obo:HP_0001999","obo:HP_0001643","obo:HP_0004209"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a5872ddd-bff5-4954-8da1-695385955a13_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ecf338e4-edde-4ef4-88b8-0eb8fc78ba9a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7ddb87d-3834-4017-a7bd-d442f2da1162","type":"EvidenceLine","dc:description":"The SD-GCEP downgrades variants for homozygosity/consanguinity","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7ddb87d-3834-4017-a7bd-d442f2da1162_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a2b0480-fb35-4b1c-873a-24eed34d259e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2576T>G (p.Val859Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384250307"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ecf338e4-edde-4ef4-88b8-0eb8fc78ba9a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30216658","rdfs:label":"Alkhunaizi_Patient 3","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a2b0480-fb35-4b1c-873a-24eed34d259e"},"detectionMethod":"WES was performed for all patients","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012443","obo:HP_0001034","obo:HP_0008586","obo:HP_0001249","obo:HP_0004691","obo:HP_0001999","obo:HP_0000007","obo:HP_0008897","obo:HP_0004209","obo:HP_0001511","obo:HP_0000252","obo:HP_0001629","obo:HP_0000365"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e7ddb87d-3834-4017-a7bd-d442f2da1162_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/beeb63b2-ef0b-4f67-9274-2f0883061c8f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3649fac-938a-48f5-82a4-6e9cf3218420","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3649fac-938a-48f5-82a4-6e9cf3218420_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36703504","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fa4bb11-775e-4d59-80eb-1dd0a89faa32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.1403dup (p.Ser469ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6501284"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/beeb63b2-ef0b-4f67-9274-2f0883061c8f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36703504","rdfs:label":"Arroyo-Carrera_proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fa4bb11-775e-4d59-80eb-1dd0a89faa32"},"detectionMethod":"Clinical exome trio was performed for the proband, and two DDX11 variants were found in trans","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000340","obo:HP_0000341","obo:HP_0000007","obo:HP_0000252","obo:HP_0008586"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e3649fac-938a-48f5-82a4-6e9cf3218420_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5f51c8d1-05f5-4946-966a-3d2d540e569b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55233620-e37b-496e-81a8-5620be53a35c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55233620-e37b-496e-81a8-5620be53a35c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","allele":{"id":"https://genegraph.clinicalgenome.org/r/77d710ca-8e40-4f32-b9f7-0112f21dda2a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.1672C>T (p.Arg558Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6501451"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/25c29ad5-a577-4319-a8b3-7ee1a77d7ee1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25c29ad5-a577-4319-a8b3-7ee1a77d7ee1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"DDX11 expression and localization in WABS01 cells expressing different DDX11 versions were assessed by immunofluorescence. G57R, S857R, and C705Y variants showed substantially increased cytoplasmic retention and a more punctuate staining pattern, while WT and R140Q localized to nucleus.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/25c29ad5-a577-4319-a8b3-7ee1a77d7ee1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","allele":{"id":"https://genegraph.clinicalgenome.org/r/d10b484c-dc6d-4167-b724-098ec92674e2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2571C>A (p.Ser857Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384250277"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5f51c8d1-05f5-4946-966a-3d2d540e569b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","rdfs:label":"van Schie_WABS05","allele":[{"id":"https://genegraph.clinicalgenome.org/r/77d710ca-8e40-4f32-b9f7-0112f21dda2a"},{"id":"https://genegraph.clinicalgenome.org/r/d10b484c-dc6d-4167-b724-098ec92674e2"}],"detectionMethod":"Bi-allelic variants in DDX11 were detected in these patients using whole exome sequencing and/or RNA sequencing, which they confirmed using Sanger sequencing of genomic DNA and cDNA","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000007","obo:HP_0004209","obo:HP_0001511","obo:HP_0001249","obo:HP_0000252","obo:HP_0000365"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/55233620-e37b-496e-81a8-5620be53a35c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/25c29ad5-a577-4319-a8b3-7ee1a77d7ee1_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/666be8c7-ff56-4f56-9faa-4f2a44476445_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb7fc65c-9ec3-4674-8f02-5daee5b7faba","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb7fc65c-9ec3-4674-8f02-5daee5b7faba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb03088e-c8c8-481f-bcea-a3321032ecd4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.2692-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6501960"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5b0eb0c7-9597-4257-992d-9be6758bf59b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b0eb0c7-9597-4257-992d-9be6758bf59b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":" DDX11 expression and localization in WABS01 cells expressing different DDX11 versions were assessed by immunofluorescence. G57R, S857R, and C705Y variants showed substantially increased cytoplasmic retention and a more punctuate staining pattern, while WT and R140Q localized to nucleus.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5b0eb0c7-9597-4257-992d-9be6758bf59b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","allele":{"id":"https://genegraph.clinicalgenome.org/r/950abbaf-c862-40df-9cb1-66bd271d274e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030653.4(DDX11):c.169G>C (p.Gly57Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384249329"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/666be8c7-ff56-4f56-9faa-4f2a44476445","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855419","rdfs:label":"van Schie_WABS02","allele":[{"id":"https://genegraph.clinicalgenome.org/r/bb03088e-c8c8-481f-bcea-a3321032ecd4"},{"id":"https://genegraph.clinicalgenome.org/r/950abbaf-c862-40df-9cb1-66bd271d274e"}],"detectionMethod":"Bi-allelic variants in DDX11 were detected in these patients using whole exome sequencing and/or RNA sequencing, which they confirmed using Sanger sequencing of genomic DNA and cDNA","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000365","obo:HP_0000007","obo:HP_0008897","obo:HP_0000252","obo:HP_0001000"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/eb7fc65c-9ec3-4674-8f02-5daee5b7faba_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5b0eb0c7-9597-4257-992d-9be6758bf59b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24f424fd-07d5-42f4-98c5-68c4a4919abd","type":"EvidenceLine","dc:description":"The SD-GCEP downgrades zebrafish models to 1 point because of the potential off-target effects of morpholinos","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/067b87db-9a26-4a09-b7df-f05f9d093ed0","type":"Finding","dc:description":"Like the human phenotype, the zebrafish model showed growth restriction and craniofacial malformations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26089203","rdfs:label":"Sun_Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/15cb0cfd-e1a4-4a26-8324-0f2de240fd2c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/473cd920-332b-4906-8b23-6c5c803c4e2d","type":"Finding","dc:description":"DDX11 cDNA rescued the phenotype in terms of chromosomal morphology and sensitivity to growth inhibition by mitomycin C or camptothecin. The authors conclude that the abnormal cellular phenotype of the affected individual is causally related to the mutations that they identified in DDX11.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137776","rdfs:label":"van der Lelij_rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d47f5c1-b14a-4797-960d-53b6dcdfa455","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3e2487e-9ca2-465e-900d-a06465fa1df6","type":"FunctionalAlteration","dc:description":"Chromosomes in the cells of the affected individual primarily had centromeric cohesion defects (“railroads”) and total “premature chromatid separation” (PCS), while WT cells had primarily normal chromosomes. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137776","rdfs:label":"van der Lelij_functional alteration"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/99d606e6-7d37-4502-bf44-bbf2db469459_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a69ae33-ca07-4aea-b150-1373068820fe","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65846de5-5a6d-4f61-a184-0af89e409820","type":"Finding","dc:description":"DDX11 is implicated in DNA binding and has been shown to suppress the transcription of rDNA, which is consistent with the cohesinopathy phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26089203","rdfs:label":"Sun_Biochemical Function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":10195,"specifiedBy":"GeneValidityCriteria11","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/IBkuX-xK6GQ","type":"GeneValidityProposition","disease":"obo:MONDO_0013252","gene":"hgnc:2736","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_99d606e6-7d37-4502-bf44-bbf2db469459-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}